X

Pharmaceutical

Earnings Summary – Akums Drugs & Pharmaceuticals Reports 14.8% Revenue Growth in Q3 FY26 Results

Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS), a pharmaceutical contract development and manufacturing organization (CDMO) announced its third-quarter and nine-month…

Alkem Laboratories Posts 11% Revenue Growth in Q3 FY26 Amid Strategic MedTech Push

Alkem Laboratories Ltd. (NSE: ALKEM), a major Indian pharmaceutical player, reported solid unaudited financial results for the third quarter ended…

Earnings Summary – Lupin Limited Reports 26.4% Revenue Growth in Third Quarter FY2026

Lupin Limited (NSE: LUPIN) is a global pharmaceutical company specializing in branded and generic formulations, biotechnology, and active pharmaceutical ingredients.…

ZIM Laboratories Q3FY26 profit rebounds on export-led growth; margins steady amid ongoing remediation and R&D push

ZIM Laboratories Limited (NSE:ZIMLAB), an India-based pharmaceutical formulations and nutraceutical company focused on oral thin films (OTF), innovative drug delivery…

Marksans Pharma Reports Q3FY26 with Revenue Growth and EBITDA Margin Expansion

About Marksans Pharma Limited Marksans Pharma Limited (NSE: MARKSANS) is an Indian pharmaceutical company headquartered in Mumbai, India, founded in…

Emcure Pharmaceuticals Q3 FY26 Earnings Results

Executive Summary Emcure Pharmaceuticals Ltd reported Q3FY26 revenues of ₹2,363 crore, up 20.38% YoY, with consolidated net profit surging 48.08%…

Mankind Pharma Q3 FY26 Earnings Results

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and…

Corona Q3 FY26 Earnings Results

Executive Summary Corona Remedies Ltd reported Q3FY26 revenues of ₹342 crore, up 14.37% YoY, with consolidated net profit increasing 39.13%…

Sun Pharmaceutical Q3 FY26 Earnings Results

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and…

Gland Pharma Q3 FY26 Earnings Results

Executive Summary Gland Pharma Ltd reported Q3FY26 revenues of ₹1,695 crore, up 22.47% YoY, with consolidated net profit rising 27.32%…